GW Pharmaceuticals Announces Proposed Public Offering of ADSs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow rise as AI boost counters US-Iran tensions
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Google defeats US bid to force ad tech sale
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
GW Pharma (GWPH) Prices 2.8M Share Offering at $90/ADS
July 13, 2016 6:19 AM EDTGW Pharmaceuticals plc (Nasdaq: GWPH) announced the pricing of an underwritten public offering by the Company. GW will issue 2,800,000 of American Depositary Shares (ADSs), representing 33,600,000 ordinary shares of GW, at a price to the public of $90.00 per ADS on the NASDAQ Global Market, raising gross proceeds of approximately $252,000,000 (before deducting underwriting discounts, commissions and offering expenses). GW has granted the... More
